Categories
Research Insights
Alzheimer’s Drug Discovery Foundation: Drug Development RFP
This program supports investigational new drug-enabling studies and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease and related dementias.
Amount: $5,000,000
Due Date: 09/30/2024 (LOI); 12/09/2024 (Full Proposal)